slotkoers
Korea S.E.
00:00:00 03-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
30.600
KRW
|
+0,99%
|
|
+8,51%
|
-23,98%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
373.967
|
299.633
|
251.355
|
228.958
|
157.795
|
830.231
|
Bedrijfswaarde
1 |
366.800
|
311.222
|
216.703
|
207.878
|
149.778
|
834.381
|
K/w-verhouding
|
-100
x
|
-16,9
x
|
-13,7
x
|
-15,2
x
|
-10,5
x
|
-52
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
96,8
x
|
166
x
|
80,5
x
|
34,6
x
|
27,1
x
|
248
x
|
Bedrijfswaarde/omzet
|
95
x
|
173
x
|
69,4
x
|
31,4
x
|
25,8
x
|
250
x
|
Bedrijfswaarde/EBITDA
|
-52,4
x
|
-31
x
|
-15,1
x
|
-17,1
x
|
-14,7
x
|
-64,2
x
|
Bedrijfswaarde/FCF
|
-30
x
|
-28,8
x
|
-20,7
x
|
-33,4
x
|
-12,6
x
|
-150
x
|
FCF Yield
|
-3,33%
|
-3,47%
|
-4,83%
|
-3%
|
-7,93%
|
-0,67%
|
Price to Book
|
8,29
x
|
10,7
x
|
4,39
x
|
3,68
x
|
2,97
x
|
22,9
x
|
Aantal aandelen (in duizenden)
|
15.327
|
15.327
|
15.327
|
20.627
|
20.627
|
20.627
|
Referentieprijs
2 |
24.400
|
19.550
|
16.400
|
11.100
|
7.650
|
40.250
|
Datum van publicatie
|
1/03/19
|
29/02/20
|
1/03/21
|
1/03/22
|
1/03/23
|
29/02/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
3.862
|
1.801
|
3.121
|
6.625
|
5.814
|
3.342
|
EBITDA
1 |
-7.006
|
-10.052
|
-14.340
|
-12.149
|
-10.172
|
-12.990
|
Bedrijfsresultaat (EBIT)
1 |
-7.906
|
-12.704
|
-17.606
|
-15.659
|
-15.227
|
-15.884
|
Operationele Marge
|
-204,72%
|
-705,32%
|
-564,17%
|
-236,37%
|
-261,9%
|
-475,3%
|
Resultaat voor belastingen (EBT)
1 |
-3.697
|
-17.626
|
-18.335
|
-15.284
|
-15.067
|
-15.941
|
Nettowinst (verlies)
1 |
-3.726
|
-17.718
|
-18.382
|
-15.042
|
-15.063
|
-15.922
|
Nettomarge
|
-96,48%
|
-983,7%
|
-589,03%
|
-227,07%
|
-259,08%
|
-476,43%
|
WPA
2 |
-243,1
|
-1.156
|
-1.196
|
-729,2
|
-730,3
|
-774,0
|
Free Cash Flow
1 |
-12.225
|
-10.791
|
-10.469
|
-6.226
|
-11.877
|
-5.568
|
FCF-marge
|
-316,56%
|
-599,13%
|
-335,48%
|
-93,98%
|
-204,29%
|
-166,62%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
1/03/19
|
29/02/20
|
1/03/21
|
1/03/22
|
1/03/23
|
29/02/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
11.589
|
-
|
-
|
-
|
4.150
|
Nettokaspositie
1 |
7.166
|
-
|
34.652
|
21.080
|
8.017
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-1,153
x
|
-
|
-
|
-
|
-0,3195
x
|
Free Cash Flow
1 |
-12.225
|
-10.791
|
-10.469
|
-6.226
|
-11.877
|
-5.568
|
ROE (netto-inkomsten/eigen vermogen)
|
-7,92%
|
-48,4%
|
-34,9%
|
-21,6%
|
-26,1%
|
-35,7%
|
ROA (netto-inkomsten/totale activa)
|
-7,92%
|
-12%
|
-12,3%
|
-10%
|
-13%
|
-16,4%
|
Totale activa
1 |
47.057
|
148.110
|
149.251
|
150.297
|
115.657
|
96.848
|
Nettoactief per aandeel
2 |
2.943
|
1.833
|
3.739
|
3.020
|
2.575
|
1.761
|
Cashflow per aandeel
2 |
117,0
|
160,0
|
3.295
|
225,0
|
244,0
|
208,0
|
Capex
1 |
10.136
|
5.007
|
3.098
|
699
|
1.525
|
731
|
Capex/omzet
|
262,46%
|
277,98%
|
99,27%
|
10,55%
|
26,23%
|
21,88%
|
Datum van publicatie
|
1/03/19
|
29/02/20
|
1/03/21
|
1/03/22
|
1/03/23
|
29/02/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -23,98% | 466 mln. | | +8,96% | 105 mld. | | -1,43% | 104 mld. | | +4,40% | 22,94 mld. | | -12,15% | 22,34 mld. | | -4,36% | 19,25 mld. | | -39,98% | 17,08 mld. | | -10,04% | 16,96 mld. | | +6,79% | 14,16 mld. | | +38,61% | 12,63 mld. |
Biotherapeutische geneesmiddelen
|